Huan Li

4.5k total citations
178 papers, 3.1k citations indexed

About

Huan Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huan Li has authored 178 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 52 papers in Cancer Research and 37 papers in Oncology. Recurrent topics in Huan Li's work include Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (22 papers) and MicroRNA in disease regulation (14 papers). Huan Li is often cited by papers focused on Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (22 papers) and MicroRNA in disease regulation (14 papers). Huan Li collaborates with scholars based in China, United States and United Kingdom. Huan Li's co-authors include Yang Liang, Robert Peter Gale, Chongxiang Chen, Ming Song, Jiaojiao Wang, Fang‐Wen Hu, Ran Tao, Qingyu Zhao, Shuwei Chen and Ying Luo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Huan Li

168 papers receiving 3.1k citations

Peers

Huan Li

ONCOL

IMMUN

Jie Xiong China

Zhichao Chen China

Colin E. Evans United States

Veronica Tisato Italy

Anna Eriksson Sweden

Daniel Sedding Germany

Roberto Pola Italy

Juanjuan Xu China

Vikas Kumar United States

Jie Tian China

Jie Xiong China

Huan Li

1.4k ×0.8

690 ×0.9

562 ×1.1

ONCOL

436 ×1.1

IMMUN

659 ×2.0

Citations per year, relative to Huan Li Huan Li (= 1×) peers Jie Xiong

Countries citing papers authored by Huan Li

Since Specialization

Citations

This map shows the geographic impact of Huan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan Li more than expected).

Fields of papers citing papers by Huan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan Li. The network helps show where Huan Li may publish in the future.

Co-authorship network of co-authors of Huan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huan Li. A scholar is included among the top collaborators of Huan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan Li. Huan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yutong, Dong Li, Junjun Chen, et al.. (2025). Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice. Materials Today Bio. 35. 102418–102418.

Yang, Zihui, Huan Li, Jun Wang, et al.. (2024). CCL2/CCR2 axis promotes perineural invasion of salivary adenoid cystic carcinoma via ITGβ5-mediated nerve-tumor interaction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167484–167484. 3 indexed citations

Li, Huan, et al.. (2024). Tumor micro-environment induced TRAIL secretion from engineered macrophages for anti-tumor therapy. Cellular Immunology. 403-404. 104857–104857. 5 indexed citations

Zheng, Qi, Xueping Yu, Airong Hu, et al.. (2024). Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics. 59(5). 692–704. 1 indexed citations

Zhang, Guihong, Jiao Liu, Sanzhong Li, et al.. (2024). Cytochalasin H enhances sensitivity to gefitinib in non-small-cell lung cancer cells through inhibiting EGFR activation and PD-L1 expression. Scientific Reports. 14(1). 25276–25276. 1 indexed citations

Zhang, Guihong, et al.. (2024). Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer. Frontiers in Bioscience-Landmark. 29(5). 189–189. 3 indexed citations

Liu, Rong, et al.. (2023). The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers. Clinical & Translational Oncology. 25(10). 3006–3020. 4 indexed citations

Li, Yue, et al.. (2023). Extracellular histones exacerbate heat stroke-induced liver injury by triggering hepatocyte pyroptosis and liver injury via the TLR9-NLRP3 pathway. International Immunopharmacology. 126. 111305–111305. 8 indexed citations

Peng, Jianmin, et al.. (2023). Radiotherapy upregulated immune checkpoints contribute to the development of second primary OSCC. Oral Diseases. 30(4). 2188–2201. 3 indexed citations

10.

Chen, Chongxiang, et al.. (2021). JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis. Leukemia. 35(9). 2616–2620. 64 indexed citations

11.

Peng, Jianmin, Qinchao Hu, Xijuan Chen, et al.. (2021). Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells. Cell Death and Disease. 12(10). 946–946. 42 indexed citations

12.

Wang, Liang, et al.. (2021). CCR2 improves homing and engraftment of adipose-derived stem cells in dystrophic mice. Stem Cell Research & Therapy. 12(1). 12–12. 11 indexed citations

13.

Li, Huan, Liang Wang, Yaqin Li, et al.. (2020). Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. Biological Research. 53(1). 22–22. 13 indexed citations

14.

Chen, Shuwei, Huan Li, Xiyuan Li, et al.. (2020). High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma. Cancer Medicine. 9(12). 4274–4289. 12 indexed citations

15.

Zhang, Nan, Ying Zhang, Ping Zhang, et al.. (2020). Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia. Therapeutic Advances in Medical Oncology. 12. 3863542675–3863542675. 6 indexed citations

16.

Liu, Xuejiao, Lin Shi, Guanzheng Liu, et al.. (2020). MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation. Journal of Cellular and Molecular Medicine. 24(13). 7550–7562. 24 indexed citations

17.

Hu, Qinchao, Tong Wu, Xiaobing Chen, et al.. (2018). The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation. Cancer Medicine. 7(4). 1056–1069. 16 indexed citations

18.

Huang, He, et al.. (2018). Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance. European Archives of Oto-Rhino-Laryngology. 275(10). 2563–2573. 15 indexed citations

19.

Wang, Haiyan, Liang Duan, Zheng‐Yu Zou, et al.. (2014). Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-induced Viability and Migration in Colorectal Cancer Cells. International Journal of Medical Sciences. 11(8). 841–849. 49 indexed citations

20.

Wang, Liwei, et al.. (2013). Reliability and validity of Chinese version of housebound scale in Chinese elderly people. Zhonghua xingwei yixue yu naokexue zazhi. 22(8). 758–760. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact